ArisGlobal Introduces NavaX-Powered Advanced Compliance Docs
AI-enabled capabilities reduce manual document authoring by up to 70–80%, ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
AI-enabled capabilities reduce manual document authoring by up to 70–80%, ...
Advancing operational visibility, coordination, and future AI-driven initiatives Boston, Massachusetts ...
ArisGlobal brings a mission-critical, AI-native platform spanning regulatory, safety, ...
New AI-enabled capabilities reduce manual data entry by up to ...
Leading global pharmaceutical organizations select ArisGlobal's AI-enabled regulatory platform to ...
Leading pharmaceutical organizations select NavaX AI to transform global pharmacovigilance ...
Next-generation Quality Management System to extend the NavaX AI platform ...
Deployment of LifeSphere Intake & Triage, Literature Intelligence, and Reporter enhances efficiency, ...
Collaboration combines AI technology and operational expertise to help life sciences organizations ...
Modular, system-agnostic product design enables rapid deployment on top of existing safety systems ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved